Germany

Germany

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.4 (0.30 - 0.50) 2016 Modelled ECDC
0.7 (0.40 - 1.10) 2002 Survey/reported Huetter ML et al, 2014
0.5 (0.40 - 0.60) 2013 Survey/reported WolfframI et al, 2015
0.67 (0.51 - 0.90) 2015 Modelled WHO
0.3 (0.20 - 0.60) 2016 Modelled Razavi-Shearer et al, 2018
0.3 (0.20 - 0.60) 2011 Survey/reported ECDC
0.7 (0.65 - 0.76) 2013 Modelled Schweitzer et al, 2015
0.36 (0.31 - 0.40) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.39 (0.35 - 0.44) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.35 - 0.44) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.36 - 0.44) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.36 - 0.46) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.36 - 0.46) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.37 - 0.46) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.42 (0.37 - 0.47) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.42 (0.37 - 0.48) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.43 (0.37 - 0.48) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.43 (0.37 - 0.49) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.43 (0.38 - 0.49) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.38 - 0.49) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.39 - 0.49) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.39 - 0.49) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.39 - 0.49) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.45 (0.40 - 0.50) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.45 (0.40 - 0.50) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.45 (0.40 - 0.51) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.45 (0.40 - 0.51) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.40 - 0.51) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.40 - 0.51) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.41 - 0.52) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.41 - 0.52) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.41 - 0.52) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.47 (0.41 - 0.52) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.47 (0.41 - 0.52) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.47 (0.42 - 0.53) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.47 (0.42 - 0.53) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.48 (0.42 - 0.54) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.34 - 0.44) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.24 (0.15 - 0.37) 2015 Modelled WHO
0.02 (0.01 - 0.02) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.03 (0.02 - 0.04) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.05) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.05) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.02 - 0.05) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.02 - 0.05) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.02 - 0.05) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.03 - 0.06) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.03 - 0.07) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.05 - 0.11) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.1 (0.07 - 0.14) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.08 - 0.17) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.09 - 0.18) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.10 - 0.19) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.10 - 0.20) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.10 - 0.20) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.10 - 0.21) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.10 - 0.22) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.17 (0.11 - 0.24) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.12 - 0.26) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.13 - 0.29) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.22 (0.15 - 0.31) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.25 (0.16 - 0.35) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.21 (0.17 - 0.24) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
241,000 (167,000 - 454,000) 2016 Modelled Razavi-Shearer et al, 2018
304,216 (266,938 - 342,425) 2019 Modelled IHME, GBD 2019 (accessed 2020)
316,416 (279,492 - 356,634) 2019 Modelled IHME, GBD 2019 (accessed 2022)
316,649 (280,032 - 351,320) 2018 Modelled IHME, GBD 2019 (accessed 2022)
317,068 (278,072 - 352,382) 2017 Modelled IHME, GBD 2019 (accessed 2022)
318,375 (283,562 - 353,203) 2016 Modelled IHME, GBD 2019 (accessed 2022)
320,147 (283,103 - 359,949) 2015 Modelled IHME, GBD 2019 (accessed 2022)
321,461 (284,598 - 360,089) 2014 Modelled IHME, GBD 2019 (accessed 2022)
323,568 (285,338 - 362,528) 2013 Modelled IHME, GBD 2019 (accessed 2022)
326,218 (285,040 - 366,273) 2012 Modelled IHME, GBD 2019 (accessed 2022)
329,151 (286,832 - 370,509) 2011 Modelled IHME, GBD 2019 (accessed 2022)
332,012 (286,064 - 376,035) 2010 Modelled IHME, GBD 2019 (accessed 2022)
334,798 (290,596 - 378,003) 2009 Modelled IHME, GBD 2019 (accessed 2022)
338,310 (294,411 - 379,881) 2008 Modelled IHME, GBD 2019 (accessed 2022)
341,862 (299,137 - 382,321) 2007 Modelled IHME, GBD 2019 (accessed 2022)
344,959 (304,066 - 385,647) 2006 Modelled IHME, GBD 2019 (accessed 2022)
347,126 (305,325 - 388,237) 2005 Modelled IHME, GBD 2019 (accessed 2022)
348,943 (307,690 - 388,752) 2004 Modelled IHME, GBD 2019 (accessed 2022)
351,267 (310,380 - 390,901) 2003 Modelled IHME, GBD 2019 (accessed 2022)
353,482 (311,787 - 394,043) 2002 Modelled IHME, GBD 2019 (accessed 2022)
355,145 (313,392 - 398,539) 2001 Modelled IHME, GBD 2019 (accessed 2022)
355,875 (314,224 - 401,481) 2000 Modelled IHME, GBD 2019 (accessed 2022)
356,412 (314,962 - 400,382) 1999 Modelled IHME, GBD 2019 (accessed 2022)
357,650 (316,254 - 400,517) 1998 Modelled IHME, GBD 2019 (accessed 2022)
359,116 (317,096 - 403,407) 1997 Modelled IHME, GBD 2019 (accessed 2022)
360,400 (317,311 - 404,327) 1996 Modelled IHME, GBD 2019 (accessed 2022)
360,974 (318,723 - 406,815) 1995 Modelled IHME, GBD 2019 (accessed 2022)
361,044 (319,262 - 404,901) 1994 Modelled IHME, GBD 2019 (accessed 2022)
361,159 (319,621 - 405,447) 1993 Modelled IHME, GBD 2019 (accessed 2022)
361,109 (319,153 - 405,060) 1992 Modelled IHME, GBD 2019 (accessed 2022)
361,018 (319,649 - 405,845) 1991 Modelled IHME, GBD 2019 (accessed 2022)
361,272 (318,894 - 408,974) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.33 (1.78 - 3.07) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.77 (2.77 - 4.98) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.81 (2.80 - 5.04) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.63 (2.67 - 4.81) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.89 (2.87 - 5.16) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.93 (2.91 - 5.20) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.93 (2.92 - 5.20) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.88 (2.88 - 5.06) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.82 (2.84 - 4.99) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.93 (2.91 - 5.14) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.8 (2.84 - 4.96) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.8 (2.83 - 4.99) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.7 (2.77 - 4.82) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.58 (2.69 - 4.66) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.41 (2.57 - 4.46) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.18 (2.39 - 4.13) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.05 (2.28 - 3.96) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.97 (2.23 - 3.82) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.92 (2.19 - 3.77) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.9 (2.18 - 3.76) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.83 (2.14 - 3.66) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.88 (2.18 - 3.74) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.72 (2.05 - 3.53) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.6 (1.95 - 3.38) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.5 (1.89 - 3.25) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.37 (1.80 - 3.11) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.37 (1.79 - 3.12) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.34 (1.78 - 3.05) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.31 (1.74 - 3.01) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.33 (1.78 - 3.07) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2.31 (1.76 - 3) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
3,703 2016 Modelled WHO
3,029 (2,229 - 4,004) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3,083 (2,267 - 4,072) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,900 (2,132 - 3,843) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3,157 (2,334 - 4,188) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3,207 (2,372 - 4,243) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3,214 (2,386 - 4,249) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3,218 (2,383 - 4,213) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3,185 (2,363 - 4,153) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3,127 (2,336 - 4,075) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3,137 (2,336 - 4,097) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3,130 (2,333 - 4,104) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,952 (2,217 - 3,847) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3,050 (2,285 - 3,971) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2,626 (1,969 - 3,408) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2,818 (2,118 - 3,679) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2,442 (1,833 - 3,146) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2,516 (1,882 - 3,262) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2,397 (1,802 - 3,097) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2,376 (1,787 - 3,080) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2,357 (1,782 - 3,061) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2,223 (1,676 - 2,879) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2,128 (1,596 - 2,762) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2,309 (1,744 - 2,992) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2,053 (1,548 - 2,666) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,955 (1,483 - 2,560) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,952 (1,482 - 2,544) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,962 (1,486 - 2,589) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,955 (1,485 - 2,539) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,944 (1,464 - 2,530) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,981 (1,509 - 2,606) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,981 (1,509 - 2,606) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
4 (3 - 6) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 6) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 6) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 7) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1999 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2000 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2002 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2001 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2003 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2004 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2005 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2006 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2008 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 11) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 11) 2012 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2013 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 11) 2019 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
87 2019 Survey/reported WHO/UNICEF
87 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
54 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
Yes
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.3 (0.10 - 0.40) 2015 Modelled Blach et al, 2017
0.86 (0.71 - 1.06) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.71 - 1.05) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.71 - 1.04) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.69 - 1) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.67 - 0.95) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.67 - 0.94) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.66 - 0.93) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.66 - 0.92) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.65 - 0.92) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.65 - 0.91) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.65 - 0.91) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.64 - 0.91) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.64 - 0.90) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.64 - 0.89) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.63 - 0.88) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.61 - 0.86) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.58 - 0.82) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.54 - 0.77) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.51 - 0.74) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.49 - 0.73) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.49 - 0.73) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.48 - 0.72) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.48 - 0.72) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.47 - 0.72) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.58 (0.47 - 0.72) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.48 - 0.72) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.51 - 0.74) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.54 - 0.79) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.58 - 0.85) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.62 - 0.92) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.66 - 1) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.11 (0.05 - 0.17) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.4 (0.30 - 0.50) 2016 Modelled ECDC
0.6 (0.30 - 1) 2002 Survey/reported Huetter ML et al, 2014
0.6 (0.30 - 0.90) 2014 Modelled Gower et al, 2014
0.58 2019 Modelled Jin et al. 2017
0.3 (0.10 - 0.50) 2011 Survey/reported ECDC
Showing out of
Show more
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
8.8 (7.60 - 10) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
65 (60.60 - 69.40) 2014 Modelled Degenhardt L et al, 2017
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
5.8 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
205,000 (90,000 - 313,000) 2015 Modelled Blach et al, 2017
576,517 (473,741 - 702,093) 1990 Modelled IHME, GBD 2019 (accessed 2022)
539,555 (446,152 - 651,965) 1991 Modelled IHME, GBD 2019 (accessed 2022)
505,548 (418,591 - 606,667) 1992 Modelled IHME, GBD 2019 (accessed 2022)
477,642 (393,578 - 576,452) 1993 Modelled IHME, GBD 2019 (accessed 2022)
459,678 (374,245 - 558,162) 1994 Modelled IHME, GBD 2019 (accessed 2022)
454,778 (366,952 - 558,355) 1995 Modelled IHME, GBD 2019 (accessed 2022)
457,159 (371,271 - 560,246) 1996 Modelled IHME, GBD 2019 (accessed 2022)
459,146 (374,596 - 563,011) 1997 Modelled IHME, GBD 2019 (accessed 2022)
461,325 (377,184 - 565,169) 1998 Modelled IHME, GBD 2019 (accessed 2022)
464,619 (380,833 - 567,945) 1999 Modelled IHME, GBD 2019 (accessed 2022)
468,822 (384,647 - 572,859) 2000 Modelled IHME, GBD 2019 (accessed 2022)
482,839 (400,941 - 581,707) 2001 Modelled IHME, GBD 2019 (accessed 2022)
510,012 (427,117 - 609,639) 2002 Modelled IHME, GBD 2019 (accessed 2022)
542,089 (455,092 - 642,272) 2003 Modelled IHME, GBD 2019 (accessed 2022)
571,211 (479,640 - 673,710) 2004 Modelled IHME, GBD 2019 (accessed 2022)
587,722 (492,194 - 693,089) 2005 Modelled IHME, GBD 2019 (accessed 2022)
593,135 (499,169 - 699,499) 2006 Modelled IHME, GBD 2019 (accessed 2022)
596,003 (501,758 - 704,241) 2007 Modelled IHME, GBD 2019 (accessed 2022)
597,537 (503,377 - 707,861) 2008 Modelled IHME, GBD 2019 (accessed 2022)
599,409 (502,780 - 708,881) 2009 Modelled IHME, GBD 2019 (accessed 2022)
602,008 (504,162 - 711,271) 2010 Modelled IHME, GBD 2019 (accessed 2022)
604,844 (509,084 - 713,610) 2011 Modelled IHME, GBD 2019 (accessed 2022)
609,138 (512,425 - 718,598) 2012 Modelled IHME, GBD 2019 (accessed 2022)
615,067 (517,306 - 725,909) 2013 Modelled IHME, GBD 2019 (accessed 2022)
623,474 (521,936 - 736,581) 2014 Modelled IHME, GBD 2019 (accessed 2022)
633,488 (528,909 - 750,786) 2015 Modelled IHME, GBD 2019 (accessed 2022)
659,377 (546,964 - 790,451) 2016 Modelled IHME, GBD 2019 (accessed 2022)
685,420 (565,900 - 833,083) 2017 Modelled IHME, GBD 2019 (accessed 2022)
694,265 (573,883 - 845,676) 2018 Modelled IHME, GBD 2019 (accessed 2022)
697,866 (572,408 - 855,048) 2019 Modelled IHME, GBD 2019 (accessed 2022)
689,423 (564,538 - 847,311) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
18,800 (8,300 - 28,700) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
6.77 (5.31 - 8.45) 2019 Modelled IHME, GBD 2019 (accessed 2020)
5.87 (4.56 - 7.63) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5.68 (4.42 - 7.38) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5.93 (4.63 - 7.67) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6.05 (4.72 - 7.83) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6.15 (4.80 - 7.94) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6.2 (4.83 - 7.99) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6.22 (4.89 - 8.03) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6.2 (4.89 - 7.98) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6.16 (4.87 - 7.94) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6.25 (4.93 - 7.97) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6.38 (5.05 - 8.10) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6.41 (5.11 - 8.08) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6.51 (5.16 - 8.24) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6.54 (5.22 - 8.26) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.59 (5.24 - 8.33) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6.54 (5.23 - 8.22) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6.52 (5.25 - 8.18) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.52 (5.26 - 8.16) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6.54 (5.28 - 8.21) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6.56 (5.30 - 8.21) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6.51 (5.25 - 8.13) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6.44 (5.20 - 8.05) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6.45 (5.13 - 8.04) 2012 Modelled IHME, GBD 2019 (accessed 2022)
6.51 (5.17 - 8.16) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6.48 (5.16 - 8.11) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6.65 (5.28 - 8.34) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6.63 (5.26 - 8.29) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6.67 (5.31 - 8.36) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6.77 (5.31 - 8.45) 2019 Modelled IHME, GBD 2019 (accessed 2022)
6.67 (5.24 - 8.30) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
6,717 2016 Modelled WHO
5,748 (4,506 - 7,178) 2019 Modelled IHME, GBD 2019 (accessed 2022)
5,748 (4,506 - 7,178) 2019 Modelled IHME, GBD 2019 (accessed 2020)
5,644 (4,437 - 7,025) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5,580 (4,429 - 6,975) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5,564 (4,431 - 6,975) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5,511 (4,376 - 6,918) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5,340 (4,253 - 6,687) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5,336 (4,239 - 6,691) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5,268 (4,194 - 6,573) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5,257 (4,241 - 6,566) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5,315 (4,284 - 6,640) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5,368 (4,332 - 6,717) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5,364 (4,331 - 6,728) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5,354 (4,319 - 6,707) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5,364 (4,324 - 6,735) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5,394 (4,307 - 6,773) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5,398 (4,303 - 6,817) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5,442 (4,327 - 6,874) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5,372 (4,260 - 6,794) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5,281 (4,211 - 6,658) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5,254 (4,157 - 6,670) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5,134 (4,051 - 6,551) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5,062 (4,000 - 6,523) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5,086 (4,014 - 6,548) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5,100 (4,007 - 6,583) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5,069 (3,950 - 6,536) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5,015 (3,913 - 6,471) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4,917 (3,837 - 6,363) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4,797 (3,743 - 6,199) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4,718 (3,669 - 6,129) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4,544 (3,535 - 5,898) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
11 (9 - 14) 1991 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 14) 1992 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1990 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 1993 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 1994 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 1995 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 17) 1996 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 18) 1997 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 19) 1998 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 21) 1999 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 24) 2000 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 25) 2001 Modelled IHME, GBD 2019 (accessed 2022)
21 (17 - 26) 2002 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 29) 2004 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 27) 2003 Modelled IHME, GBD 2019 (accessed 2022)
24 (19 - 30) 2005 Modelled IHME, GBD 2019 (accessed 2022)
25 (19 - 31) 2006 Modelled IHME, GBD 2019 (accessed 2022)
25 (20 - 31) 2007 Modelled IHME, GBD 2019 (accessed 2022)
26 (20 - 32) 2008 Modelled IHME, GBD 2019 (accessed 2022)
25 (19 - 32) 2009 Modelled IHME, GBD 2019 (accessed 2022)
25 (19 - 31) 2010 Modelled IHME, GBD 2019 (accessed 2022)
25 (19 - 31) 2011 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 31) 2013 Modelled IHME, GBD 2019 (accessed 2022)
24 (19 - 31) 2012 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 31) 2014 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 31) 2015 Modelled IHME, GBD 2019 (accessed 2022)
24 (18 - 31) 2016 Modelled IHME, GBD 2019 (accessed 2022)
25 (18 - 31) 2017 Modelled IHME, GBD 2019 (accessed 2022)
25 (18 - 32) 2018 Modelled IHME, GBD 2019 (accessed 2022)
25 (18 - 32) 2019 Modelled IHME, GBD 2019 (accessed 2022)
31 (23 - 39) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
54 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HBV testing policy
Pregnant women, Risk-based
Source:
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
Yes
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

HBV (HBsAg+)
0.39 (%)
2019
(0.34 - 0.44(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
0.86 (%)
2019
(0.71 - 1.06(%))
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

HBV (HBsAg+)
0.5 (%)
2013
(0.4 - 0.6(%))
WolfframI et al, 2015
HCV (anti-HCV)
0.3 (%)
2011
(0.1 - 0.5(%))
ECDC

Hepatitis related deaths (national)

Modelled

HBV
1,981
2019
(1,509 - 2,606)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
5,748
2019
(4,506 - 7,178)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.21 (%)
2020, latest modelled
(0.17 - 0.24(%))
WHO

Prevalence PWID

HCV
65 (%)
2014, latest modelled
(60.60 - 69.40(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

Action plan

View all

News

Action plans

Resources

Partners